These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6367971

  • 1. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.
    Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
    Egorin MJ, Van Echo DA, Tipping SJ, Olman EA, Whitacre MY, Thompson BW, Aisner J.
    Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
    [Abstract] [Full Text] [Related]

  • 3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA) in humans].
    Zucca E, Cattaneo MT, Cavalli F, Guaitani A, Filipazzi V, Bartosek I.
    G Ital Chemioter; 1985 Nov; 32(1):25-8. PubMed ID: 3913618
    [No Abstract] [Full Text] [Related]

  • 5. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
    Curt GA, Grygiel JJ, Corden BJ, Ozols RF, Weiss RB, Tell DT, Myers CE, Collins JM.
    Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J, Boven E, Vermorken JB, Gall HE, van der Vijgh WJ.
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [Abstract] [Full Text] [Related]

  • 8. Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHIC.
    Gouyette A, Ducret JP, Caillé P, Amiel JL, Rouëssé J, Foka M, Carde P, Hayat M, Sancho-Garnier H.
    Anticancer Res; 1986 Sep; 6(5):1127-32. PubMed ID: 3800320
    [Abstract] [Full Text] [Related]

  • 9. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patients.
    Sharma H, Thatcher N, Baer J, Zaki A, Smith A, McAucliffe CA, Crowther D, Owens S, Fox BW.
    Cancer Chemother Pharmacol; 1983 Sep; 11(1):5-7. PubMed ID: 6349844
    [Abstract] [Full Text] [Related]

  • 10. Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
    Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW.
    Cancer Res; 1982 Nov; 42(11):4831-5. PubMed ID: 7127319
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK.
    Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetics of carboplatin (CBDCA) and tissue concentration of platinum in gynecologic organs].
    Fujiwara K, Miyagi Y, Hayase R, Yoshinouchi M, Kobashi Y, Kohno I, Sekiba K.
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1943-8. PubMed ID: 3289504
    [Abstract] [Full Text] [Related]

  • 13. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
    Ueda T, Yasumasu T, Uozumi J.
    J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
    Láznícková A, Láznícek M, Kvĕtina J, Drobník J.
    Cancer Chemother Pharmacol; 1986 Aug; 17(2):133-6. PubMed ID: 3521926
    [Abstract] [Full Text] [Related]

  • 15. Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
    Schilder RJ, LaCreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D.
    Cancer Res; 1994 Feb 01; 54(3):709-17. PubMed ID: 8306332
    [Abstract] [Full Text] [Related]

  • 16. Clinical pharmacokinetics of oxaliplatin: a critical review.
    Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E.
    Clin Cancer Res; 2000 Apr 01; 6(4):1205-18. PubMed ID: 10778943
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y, Tamura T, Eguchi K, Shinkai T, Fujiwara Y, Fukuda M, Ohe Y, Bungo M, Horichi N, Niimi S.
    Cancer Chemother Pharmacol; 1989 Apr 01; 23(4):243-6. PubMed ID: 2647312
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
    Ota K, Oguma T, Shimamura K.
    Anticancer Res; 1994 Apr 01; 14(3B):1383-7. PubMed ID: 8067710
    [Abstract] [Full Text] [Related]

  • 19. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A, Semecký V, Láznícek M, Zubr V, Koksál J, Kvĕtina J.
    Neoplasma; 1989 Apr 01; 36(2):161-9. PubMed ID: 2654665
    [Abstract] [Full Text] [Related]

  • 20. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.
    Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR.
    Cancer Chemother Pharmacol; 1982 Apr 01; 9(3):140-7. PubMed ID: 6761010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.